A cluster analysis of epidemiological and clinical factors associated with the accumulation process of the burden of COVID-19 in European countries.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
10 11 2020
Historique:
received: 25 06 2020
accepted: 03 08 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 17 3 2021
Statut: epublish

Résumé

Background and aim of the work European COVID-19 statistics showed differentiation between mortality and new cases. Some studies suggested several factors including migration, cancer incidence, life expectancy and health system capacity maybe associated with differentiations. Up to now, impact of those factors in different European societies is not discussed and compared. Aim of the present study was to perform the cluster analysis in European countries in attention to clinical and epidemiological factors due to covid-19. Methods We collected some appropriate extreme data of COVID-19 to access the situations by ANOVA post-hoc test in 3 scenarios, as well as to estimate regression coefficients in simple linear regression, and a cluster analysis using average linkage. Covid-19 Statistics were considered in all analyses until April 24, 2020. Results Among 39 European countries, several countries reported highest rate of confirmed cases included of Italy (current statues=2270.52) and Spain (current status=2616.24). The highest rate of mortality was seen in France (current status=242.16), Italy (current status=305.52). Life expectancy (female) (P=0.01, 95%Cl=1521.27,15264.58), migration (P<0.001, 95%Cl=41.42,96.72) had significant association with confirmed cases and death. Overall cancer death (P<0.001, 95%Cl=0.36,0.68; P<0.001, 95%Cl=0.01,0.07) and lung cancer death (P<0.001, 95%Cl=1.97,3.56; P<0.001, 95%Cl=0.09,0.37) associated with confirmed cases and mortality, too. We were also determined 5 clusters which more than 30 countries were categorized in the first cluster. Conclusions Demographic factors, including population, life expectancy and migration, underlying disorders, such as several types of cancers, especially lung cancers lead to various distribution of COVID-19 in terms of prevalence and mortality, across European counties.

Identifiants

pubmed: 33682803
doi: 10.23750/abm.v92i1.10090
pmc: PMC7975970
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021022

Références

Lancet Respir Med. 2020 Jun;8(6):542-544
pubmed: 32278368
Int J Environ Res Public Health. 2020 Mar 04;17(5):
pubmed: 32143519
J Clin Virol. 2020 May;126:104345
pubmed: 32278298
Public Health. 2020 Feb;179:A1-A2
pubmed: 32111295
Crit Rev Oncol Hematol. 2020 Jun;150:102972
pubmed: 32344317
Int J Antimicrob Agents. 2020 May;55(5):105955
pubmed: 32234468
ESMO Open. 2020 Apr;5(2):e000765
pubmed: 32245904
Anaesth Crit Care Pain Med. 2020 Apr;39(2):163-166
pubmed: 32088344
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Thorac Cancer. 2020 Jun;11(6):1752-1757
pubmed: 32291968
BMJ. 2020 Mar 26;368:m1213
pubmed: 32217531
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3434-3436
pubmed: 32329810
BMJ. 2020 Apr 1;369:m1327
pubmed: 32238354

Auteurs

Sajad Shojaee (S)

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.. sajad.shojaei.stat@gmail.com.

Pegah Eslami (P)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . pegahslm@gmail.com.

Arash Dooghaie Moghadam (A)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . arashddm@gmail.com.

Mohamad Amin Pourhoseingholi (MA)

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.. aminphg@gmail.com.

Sara Ashtari (S)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . sara_ashtari@yahoo.com.

Amir Vahedian-Azimi (A)

Trauma research center, Nursing Faculty, Baqiyatallah University of Medical Sciences, Tehran, Iran.. amirvahedian63@gmail.com.

Mohammad Reza Zali (MR)

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . nnzali@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH